These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2872567

  • 1. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
    Flaim KE, Gessner GW, Crooke ST, Heys JR, Weinstock J.
    Life Sci; 1986 Jun 09; 38(23):2087-96. PubMed ID: 2872567
    [Abstract] [Full Text] [Related]

  • 2. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM, Waddington JL.
    Neuropharmacology; 1992 Feb 09; 31(2):177-83. PubMed ID: 1532443
    [Abstract] [Full Text] [Related]

  • 3. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
    Flaim KE, Gessner GW, Crooke ST, Sarau HM, Weinstock J.
    Life Sci; 1985 Apr 15; 36(15):1427-36. PubMed ID: 2858801
    [Abstract] [Full Text] [Related]

  • 4. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK, Ross GM, Bajwa SB, Mishra RK.
    Neurochem Res; 1990 Jun 15; 15(6):647-57. PubMed ID: 1977093
    [Abstract] [Full Text] [Related]

  • 5. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
    Makman MH, Dvorkin B.
    Brain Res; 1986 Dec 15; 387(3):261-70. PubMed ID: 2950967
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum.
    Cincotta M, de Vries DJ, Beart PM.
    Neurosci Lett; 1985 Oct 24; 61(1-2):85-9. PubMed ID: 2867505
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB, Otsuka NY, Dumbrille-Ross A, Grigoriadis D, Tirpak A, Seeman P.
    J Biol Chem; 1986 Jun 25; 261(18):8397-406. PubMed ID: 3522568
    [Abstract] [Full Text] [Related]

  • 8. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X, Segawa T.
    Eur J Pharmacol; 1989 Aug 03; 166(3):401-10. PubMed ID: 2680521
    [Abstract] [Full Text] [Related]

  • 9. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
    Faedda G, Kula NS, Baldessarini RJ.
    Biochem Pharmacol; 1989 Feb 01; 38(3):473-80. PubMed ID: 2563653
    [Abstract] [Full Text] [Related]

  • 10. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G, Norman AB, Hess EJ, Creese I.
    J Neurochem; 1986 Apr 01; 46(4):1180-5. PubMed ID: 3005508
    [Abstract] [Full Text] [Related]

  • 11. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
    Gredal O, Nielsen M.
    J Neurochem; 1987 Feb 01; 48(2):370-5. PubMed ID: 3491877
    [Abstract] [Full Text] [Related]

  • 12. Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.
    Sibley DR, Leff SE, Creese I.
    Life Sci; 1982 Aug 16; 31(7):637-45. PubMed ID: 6127585
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
    Billard W, Ruperto V, Crosby G, Iorio LC, Barnett A.
    Life Sci; 1984 Oct 29; 35(18):1885-93. PubMed ID: 6387355
    [Abstract] [Full Text] [Related]

  • 14. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 15. DA1 dopamine receptors in renal cortical collecting duct.
    Ohbu K, Felder RA.
    Am J Physiol; 1991 Nov 02; 261(5 Pt 2):F890-5. PubMed ID: 1683170
    [Abstract] [Full Text] [Related]

  • 16. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ, Albers LJ, Le H, Creese I.
    J Pharmacol Exp Ther; 1986 Sep 02; 238(3):846-54. PubMed ID: 3018223
    [Abstract] [Full Text] [Related]

  • 17. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
    Zhang X, Segawa T.
    Jpn J Pharmacol; 1989 Jul 02; 50(3):333-45. PubMed ID: 2569545
    [Abstract] [Full Text] [Related]

  • 18. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
    Murray AM, Waddington JL.
    Eur J Pharmacol; 1989 Feb 07; 160(3):377-84. PubMed ID: 2565818
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J, Hyttel J, Perregaard J.
    Eur J Pharmacol; 1987 Jan 13; 133(2):137-45. PubMed ID: 2949991
    [Abstract] [Full Text] [Related]

  • 20. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Oct 30; 106(1):219-20. PubMed ID: 6241567
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.